Clinical Trial Supply New England 2016

9-10 March 2016, Boston, MA

Discover solutions to a range of challenges in the clinical trial supply industry from 9-10 March in Boston at Arena International's 5th Annual Clinical Trial Supply New England conference.

The event will bring together industry professionals to investigate challenges in packaging and labelling, comparator sourcing and logistics.

The Annex 6 label update, due to come into effect in May 2016, may cause companies unwanted problems and added stress. Mike Dallman from Cubist Pharma will be providing his insight and recommendations on the issue.

It is important for companies to plan ahead. This event will be an ideal place to share experiences and understand how others plan on addressing the updates.

The range of high-calibre speakers include:

  • Biogen Global Supply Chain Planning manager Paul Larochelle
  • Takeda Pharmaceuticals associate director Julie Jacobs
  • Customs and Border Protection US port director Helen Sterling
  • Pfizer supply chain co-ordinator Laurie Berry

This is an event designed for small to medium biotech and pharmaceutical companies, which provides the opportunity to listen to speeches from industry experts.

It also offers the chance to take part in panel and roundtable discussions with speakers to create an excellent networking opportunity and learning experience.

For a list of speakers and other information about the event and the programme, please visit www.arena-international.com/ctsnewengland/

When registering please quote the reference code MK-EGMP.